Cetuximab (anti-EGFR)

CAS No. 205923-56-4

Cetuximab (anti-EGFR) ( C225 )

Catalog No. M21142 CAS No. 205923-56-4

Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 260 Get Quote
5MG 434 Get Quote
10MG 627 Get Quote
25MG 981 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cetuximab (anti-EGFR)
  • Note
    Research use only not for human use.
  • Brief Description
    Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).
  • Description
    Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).
  • Synonyms
    C225
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    cancer
  • Indication
    Colorectal Cancer

Chemical Information

  • CAS Number
    205923-56-4
  • Formula Weight
    2756.23
  • Molecular Formula
    C107H179N35O36S7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huang S M Bock J M Harari P M . Epidermal Growth Factor Receptor Blockade with C225 Modulates Proliferation Apoptosis and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck1[J]. Cancer Res 1999 59(8):1935-1940.
molnova catalog
related products
  • Nimotuzumab

    Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).

  • AG-1517

    PD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.

  • Glaucocalyxin A

    Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.